Online healthcare marketplace Sesame closed a $27 million Series B funding round on Tuesday, bringing its total funding to $75 million. David Goldhill, CEO of the New York-based startup, said the company is "an Expedia for medical care" because patients can buy the care they want directly online, without the middleman of an insurance company.
Don't miss out on this valuable opportunity to meet and discuss the latest trends and opportunities. Don't miss your chance to save with the Super Early Bird Rate.
Drug prices are on the minds of patients and politicians. The November election is expected to tip the balance of power in Congress and a panel held during the Biotechnology Innovation Organization's annual meeting discussed what that change could mean for drug price legislation.
The Court unanimously ruled it was unlawful for HHS to adjust reimbursement rates for hospitals participating in the federal 340B program without first conducting a survey.
Rapid and effective research is the only way to stave off massive loss of human life over the next 50 years. Fortunately, there are three things we can do right now to give researchers the tools and support they'll need in the near future.
Carilion Clinic, a health system based in Roanoke, Virginia, recently unveiled its partnership with TytoCare, a New York City-based telehealth company. The partnership aims to strengthen the health system's ability to diagnose and treat patients remotely with virtual physical examinations.
By Stephanie Baum Wednesday, June 15, 2022 9:15 AM
Employee benefits is the theme of the MedCity INVEST Digital Health conference in Dallas September 28, in collaboration with Health Wildcatters. We're looking for startups across insurance, care navigation and those that help to improve and provide ROI on employee benefits programs. The application deadline is July 15.
RPM as we know it today – with all its advantages – falls short. The reason? Monitoring and alerting alone cannot provide one of the most critical parts of healthcare: care itself.
No comments